116 related articles for article (PubMed ID: 26245015)
1. Prevalence of Metabolic Syndrome in Patients with HIV in the Era of Highly Active Antiretroviral Therapy.
Lombo B; Alkhalil I; Golden MP; Fotjadhi I; Ravi S; Virata M; Lievano M; Diez J; Ghantous A; Donohue T
Conn Med; 2015 May; 79(5):277-81. PubMed ID: 26245015
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
3. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia.
Tesfaye DY; Kinde S; Medhin G; Megerssa YC; Tadewos A; Tadesse E; Shimelis T
Diabetes Metab Syndr; 2014; 8(2):102-7. PubMed ID: 24907175
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical correlates of metabolic syndrome in Nigerians living with human immunodeficiency virus/acquired immunodeficiency syndrome.
Ayodele OE; Akinboro AO; Akinyemi SO; Adepeju AA; Akinremi OA; Alao CA; Popoola AA
Metab Syndr Relat Disord; 2012 Oct; 10(5):373-9. PubMed ID: 22799758
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of metabolic syndrome among human immunodeficiency virus-infected subjects is widely influenced by the diagnostic criteria.
Cubero JM; Domingo P; Sambeat M; Ordoñez-Llanos J; Rodriguez-Espinosa J; Sánchez-Quesada JL; Pérez A
Metab Syndr Relat Disord; 2011 Oct; 9(5):345-51. PubMed ID: 21542770
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy.
Hansen BR; Petersen J; Haugaard SB; Madsbad S; Obel N; Suzuki Y; Andersen O
HIV Med; 2009 Jul; 10(6):378-87. PubMed ID: 19490178
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome in French HIV-infected patients: prevalence and predictive factors after 3 years of antiretroviral therapy.
Biron A; Bobin-Dubigeon C; Volteau C; Piroth L; Perré P; Leport C; Prazuck T; Jovelin T; Billard M; Sébille V; Bard JM; Raffi F; Biron C
AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1672-8. PubMed ID: 22731114
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment.
Calza L; Colangeli V; Magistrelli E; Rossi N; Rosselli Del Turco E; Bussini L; Borderi M; Viale P
HIV Clin Trials; 2017 May; 18(3):110-117. PubMed ID: 28420298
[TBL] [Abstract][Full Text] [Related]
10. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
[TBL] [Abstract][Full Text] [Related]
11. Independent predictors of metabolic syndrome in HIV-infected patients.
Alencastro PR; Fuchs SC; Wolff FH; Ikeda ML; Brandão AB; Barcellos NT
AIDS Patient Care STDS; 2011 Nov; 25(11):627-34. PubMed ID: 21936688
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey.
Ravikiran M; Bhansali A; Ravikumar P; Bhansali S; Dutta P; Thakur JS; Sachdeva N; Bhadada S; Walia R
Diabetes Res Clin Pract; 2010 Aug; 89(2):181-8. PubMed ID: 20381187
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and body composition changes after six months of highly active antiretroviral therapy in northern Indian patients.
Gupta V; Biswas A; Sharma SK
Int J STD AIDS; 2011 Jan; 22(1):46-9. PubMed ID: 21364067
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.
Mondy K; Overton ET; Grubb J; Tong S; Seyfried W; Powderly W; Yarasheski K
Clin Infect Dis; 2007 Mar; 44(5):726-34. PubMed ID: 17278068
[TBL] [Abstract][Full Text] [Related]
15. [Metabolic syndrome in HIV-infected patients with favorable response to antiretroviral therapy].
Prisicăriu LJ; Dorobat CM; Manciuc C; Nicolau IC
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):776-80. PubMed ID: 22046786
[TBL] [Abstract][Full Text] [Related]
16. [Metabolic syndrome and cardiovascular risk patients under antiretrovirals in a day hospital at Bobo-Dioulasso (Burkina Faso)].
Sawadogo A; Sanou S; Hema A; Kamboule BE; Kabore NF; Sore I; Konate A; Poda GE; Zoungrana J; Sawadogo AB
Bull Soc Pathol Exot; 2014 Aug; 107(3):151-8. PubMed ID: 24953144
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
18. Features of Metabolic Syndrome and Its Associated Factors during Highly Active Antiretroviral Therapy in Ouagadougou (Burkina Faso).
Guira O; Tiéno H; Diendéré AE; Sagna Y; Diallo I; Yaméogo B; Zoungrana L; Yaméogo TM; Bognounou R; Drabo JY
J Int Assoc Provid AIDS Care; 2016; 15(2):159-63. PubMed ID: 26307211
[TBL] [Abstract][Full Text] [Related]
19. Association of metabolic risk factors with uncontrolled hypertension: comparison of the several definitions of metabolic syndrome.
Cortez-Dias N; Martins SR; Belo A; Fiuza M;
J Hypertens; 2013 Oct; 31(10):1991-7. PubMed ID: 23811998
[TBL] [Abstract][Full Text] [Related]
20. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome.
Gazzaruso C; Bruno R; Garzaniti A; Giordanetti S; Fratino P; Sacchi P; Filice G
J Hypertens; 2003 Jul; 21(7):1377-82. PubMed ID: 12817187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]